MRC value | HAD anxiety score | HAD depression score | EORTC score | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient no | Test 2 | Test 3 | Test 2 | Test 3 | Test 2 | Test 3 | Test 2 | Test 3 | ||||||
1 | 1 | 2 | 5 | 4 | 10 | 5 | 58.3 | 66.7 | ||||||
2 | 1 | 3 | 14 | 13 | 9 | 11 | 50 | 41.7 | ||||||
3 | 0 | 1 | 0 | 0 | 2 | 3 | 66.7 | 75 | ||||||
4 | 1 | 1 | 0 | 0 | 3 | 2 | 83.3 | 75 | ||||||
5 | 0 | 1 | 0 | 1 | 4 | 6 | 75 | 50 | ||||||
6 | 1 | 2 | 12 | 14 | 7 | 5 | 100 | 66.7 | ||||||
7 | 3 | 3 | 7 | 5 | 9 | 9 | 58.3 | 50 | ||||||
9 | 2 | 1 | 7 | 7 | 5 | 5 | 66.7 | 66.7 | ||||||
11 | 2 | 3 | 9 | 7 | 2 | 6 | 66.7 | 66.7 | ||||||
15 | 0 | 0 | 2 | 2 | 4 | 3 | 66.7 | 83.3 | ||||||
18 | 0 | 0 | 8 | 10 | 9 | 10 | 50 | 41.7 | ||||||
20 | 2 | 2 | 17 | 15 | 17 | 20 | 0 | 25 | ||||||
21 | 0 | 1 | 8 | 13 | 5 | 6 | 83.3 | 91.6 | ||||||
22 | 1 | 0 | 0 | 0 | 2 | 1 | 83.3 | 75 | ||||||
23 | 3 | 3 | 0 | 3 | 3 | 3 | 41.7 | 41.7 | ||||||
24 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 50 | ||||||
25 | 3 | 3 | 7 | 5 | 9 | 12 | 58.3 | 66.7 | ||||||
26 | 4 | 4 | 12 | 12 | 16 | 16 | 50 | 50 | ||||||
28 | 1 | 1 | 10 | 10 | 10 | 12 | 50 | 50 | ||||||
29 | 1 | 2 | 9 | 7 | 6 | 5 | 66.7 | 66.7 | ||||||
31 | 0 | 0 | 7 | 7 | 6 | 6 | 50 | 50 | ||||||
32 | 2 | 1 | 7 | 5 | 5 | 3 | 50 | 66.7 | ||||||
Median | 1.0 | 1.0 | 7.0 | 6.0 | 5.5 | 5.5 | 62.5 | 66.7 | ||||||
p value3-150 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
Range | 0–4 | 0–17 | 0–20 | 0–100 |
↵3-150 Wilcoxon signed rank test.
MRC = modified Medical Research Council dyspnoea scale; HAD = Hospital Anxiety and Depression scale; EORTC = European Organisation for Research Trials and Cancer.